A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract ...

The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...

The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.

A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug approved in decades and the first in a new class of medications. British ...

For the longest the only treatment available for an uncomplicated UTI was nitrofurantoin. But now, FDA has approved Blujepa, another drug that can treat it. Read on to know more.

GSK’s Blujepa receives US FDA nod to treat uncomplicated urinary tract infections in female and paediatric patients 12 years of age and older: Philadelphia Friday, March 28, 202 ...

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children over the age of 12 with uncomplicated UTIs caused by bacteria including E.

Myös oikeusministeri Leena Meri on aiemmin todennut, että hallitus tuskin antaa kansalaisaloitteesta lakiesitystä.

Koulutus on yksi hallituksen rasisminvastaisen kampanjan toimista. Avaa kuvien katselu Hallituksen käynnistämän rasismin vastaisen kampanjan slogan on ”me puhumme teoin”. Kampanja julkaistiin ...

TUESDAY, March 25, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women ...